The role of endogenous IFN-γ, TNF-α and IL-10 LPS-induced nitric oxide release in a mouse model

Cytokine

Volumn 10, Issue 2, 1998, Pages 115-123

  Ter Steege, Jessica C A ^a   Van De Ven, Monique W C M ^b   Forget, Pierre Ph ^a   Brouckaert, Peter ^c   Buurman, Wim A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Endotoxin; IFN ; IL 10; Nitric oxide; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALIA;

EID: 0032007308     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0263     Document Type: Article

References (39)

1. 1. Nussler AK, Billiar TR (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 54:171-178.
2. 2. Worall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB Jr (1995) Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 181:63-70.
3. 3. Vallance P, Moncada S (1993) Role of endogenous nitric oxide in septic shock. New Horizons 1:77-86.
4. 4. Tiao G, Rafferty J, Ogle C, Fischer JE, Hasselgren PO (1994) Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116:332-338.
5. Moilanen E, Vapaatalo H (1995) Nitric oxide in inflammation and immune response. Ann Med 27:359-367.
6. 6. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG (1991) L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol 200:205-209.
7. 7. Asai K, Kato H, Kimura S, Mukai S, Kawahito Y, Sano H, Kondo M, Akaogi K, Hirose K (1996) Induction of gene expression for nitric oxide by immunomodulating drugs in the RAW265.7 murine macrophage cell line. Cancer Immunol Immun 42:275-279.
8. 8. Feinstein DL, Galea E, Roberts S, Berquist H, Wang H, Reis DJ (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 62:315-321.
9. 9. Maru A, Jackson SK (1996) Opposite effects of interleukin-4 and interleukin-10 on nitric oxide production in murine macrophages. Mediators Inflam 5:110-112.
10. 10. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25:1101-1104.
11. 11. Martin E, Nathan C, Xie Q (1994) Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180:977-984.
12. 12. Zídek Z, Lotzová E, Franková D, Savary CA (1996) Indirect stimulatory effects of murine interleukin-12 on in vitro production of nitric oxide by mouse peritoneal cells. J Interferon Cytokine Res 16:339-346.
13. 13. Chen B, Stout R, Campell WF (1996) Nitric oxide production: a mechanism of Chlamydia trachomati inhibition in interferon-γ-treated RAW264.7 cells. FEMS Immunol Med Mic 14:109-120.
14. 14. Yuhas Y, Kaminsky E, Mor M, Ashkenazi S (1996) Induction of nitric oxide production of mouse macrophages by shiga toxin. J Med Microbiol 45:97-102.
15. 15. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F (1994) Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 152:3514-3521.
16. 16. Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550.
17. 17. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL (1995) Neutralization of IL-10 increases lethality in endotoxemia. J Immunol 155:2222-2229.
18. 18. Bemelmans MHA, Gouma DJ, Buurman WA (1993) LPS-induced sTNF-Receptors release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-γ. J Immunol 151:5554-5562.
19. 19. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA (1994) Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 152:4036-4043.
20. 20. Perretti M, Szabó C, Thiemermann C (1995) Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharm 116:2251-2257.
21. 21. Sands WA, Bulut V, Severn A, Xu D, Liew FY (1994) Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Eur J Immunol 24:2345-2350.
22. 22. Engelberts I, Von Asmuth EJU, Van Der Linden CJ, Buurman WA (1991) The interrelation between TNF-α, IL-6 and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res 10:127-131.
23. 23. Jacobs P, Radzioch D, Stevenson MM (1996) In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4 during blood stage malaria in mice. Infect Immun 64:44-49.
24. 24. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor P55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827-835.
25. 25. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LMC, Moncada S, Carrier M, O'Donnell CA, Liew FY (1994) Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and IL-1-β. Immunol 81:211-215.
26. 26. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M (1994) The protective role of endogenously synthesized nitric oxide in Staphylococcal Enterotoxin B-induced shock in mice. J Exp Med 180:1153-1158.
27. 27. Salkowski CA, Detore G, McNally R, Van Rooijen N, Vogel SN (1997) Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. The roles of macrophages, endogenous IFN-γ, and TNF receptor-1-mediated signaling. J Immunol 158:905-912.
28. 28. Barsig J, Küsters S, Vogt K, Volk HD, Tiegs G, Wendel A (1995) Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur J Immunol 25:2888-2893.
29. 29. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM (1994) Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24:2699-2705.
30. 30. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA (1992) Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 149:1666-1670.
31. 31. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:789-802.
32. 32. Erickson SL, de Sauvage FJ, Kikly K, Carver Moore K, Pitts Meek S, Gillet N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
33. 33. Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B (1996) Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int Immunol 8:23-36.
34. 15N)nitrate in biological fluids. Anal Biochem 126:131-138.
35. 35. Dentener MA, Greve JW, Maessen JG, Buurman WA (1989) Role of tumor necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharm Immunot 11:321-324.
36. 36. Röllinghoff M, Warner NL (1973) Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc Soc Exp Biol Med 144:813-818.
37. 37. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105.
38. 38. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
39. 39. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416.